The purpose of this study is to determine whether the drug alirocumab, which may lower
cholesterol, can reduce the amount of inflammation caused by an infection that has caused
either low blood pressure or difficulty breathing. Participants will be randomized to receive
a single IV infusion of alirocumab or a placebo.